Shilpa Medicare
- Advice
- Hold
Shilpa Medicare Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Shilpa Medicare
Start SIPShilpa Medicare Investment Rating
-
Master Rating:
-
Shilpa Medicare Limited has an operating revenue of Rs. 1,050.12 Cr. on a trailing 12-month basis. An annual revenue de-growth of -8% needs improvement, Pre-tax margin of -3% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 8 which is a POOR score indicating inconsistency in earnings, a RS Rating of 9 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 66 | 52 | 69 | 61 | 73 |
| Operating Expenses Qtr Cr | 80 | 62 | 93 | 56 | 74 |
| Operating Profit Qtr Cr | -14 | -10 | -24 | 5 | -2 |
| Depreciation Qtr Cr | 12 | 12 | 12 | 10 | 10 |
| Interest Qtr Cr | 7 | 7 | 5 | 3 | 2 |
| Tax Qtr Cr | 2 | -7 | -4 | 0 | 0 |
| Net Profit Qtr Cr | -29 | -5 | -17 | 108 | 35 |
Shilpa Medicare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹247.87
- 50 Day
- ₹251.84
- 100 Day
- ₹262.92
- 200 Day
- ₹297.67
- 20 Day
- ₹251.6
- 50 Day
- ₹248.97
- 100 Day
- ₹255.04
- 200 Day
- ₹296.01
Shilpa Medicare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹240.77 |
| Second Resistance | ₹242.74 |
| Third Resistance | ₹244.12 |
| RSI | 34.55 |
| MFI | 21.7 |
| MACD Single Line | -2.14 |
| MACD | -4.01 |
| Support | |
|---|---|
| First Resistance | ₹237.42 |
| Second Resistance | ₹236.04 |
| Third Resistance | ₹234.07 |
Shilpa Medicare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 143,315 | 6,631,185 | 46.27 |
| Week | 248,784 | 8,869,164 | 35.65 |
| 1 Month | 259,353 | 8,996,963 | 34.69 |
| 6 Month | 962,592 | 15,979,027 | 16.6 |
Shilpa Medicare Result Highlights
Shilpa Medicare Synopsis
NSE-Medical-Diversified
Shilpa Medicare L is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 247.70 Cr. and Equity Capital is Rs. 8.68 Cr. for the Year ended 31/03/2023. Shilpa Medicare Ltd. is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739.| Market Cap | 2,061 |
| Sales | 248 |
| Shares in Float | 4.34 |
| No of funds | 58 |
| Yield | 0.46 |
| Book Value | 0.98 |
| U/D Vol ratio | 1.2 |
| LTDebt / Equity | 6 |
| Alpha | -0.25 |
| Beta | 0.57 |
Shilpa Medicare
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 50.01% | 50.01% | 50.01% | 50.01% |
| Mutual Funds | 0.05% | 1.01% | 1.01% | |
| Foreign Portfolio Investors | 13.73% | 15.32% | 14.46% | 14.41% |
| Individual Investors | 24.05% | 21.85% | 18.95% | 20.51% |
| Others | 12.21% | 12.77% | 15.57% | 14.06% |
Shilpa Medicare Management
| Name | Designation |
|---|---|
| Mr. Omprakash Inani | Chairman |
| Mr. Vishnukant Chaturbhuj Bhutada | Managing Director |
| Mr. Sharath Reddy Kalakota | Whole Time Director |
| Ms. Sirisha Chintapalli | Independent Woman Director |
| Mr. Hetal Madhukant Gandhi | Independent Director |
| Mr. Arvind Vasudeva | Independent Director |
| Dr. Kamal K Sharma | Independent Director |
| Dr. Anita Bandyopadhyay | Independent Director |
Shilpa Medicare Forecast
Price Estimates
Shilpa Medicare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-25 | Audited Results | |
| 2023-02-14 | Quarterly Results | |
| 2022-11-11 | Quarterly Results | |
| 2022-08-11 | Quarterly Results | |
| 2022-05-23 | Audited Results & Dividend |
Shilpa Medicare FAQs
What is Share Price of Shilpa Medicare ?
Shilpa Medicare share price is ₹237 As on 01 June, 2023 | 16:50
What is the Market Cap of Shilpa Medicare ?
The Market Cap of Shilpa Medicare is ₹2064.1 Cr As on 01 June, 2023 | 16:50
What is the P/E ratio of Shilpa Medicare ?
The P/E ratio of Shilpa Medicare is -63.6 As on 01 June, 2023 | 16:50
What is the PB ratio of Shilpa Medicare ?
The PB ratio of Shilpa Medicare is 1.2 As on 01 June, 2023 | 16:50